Setmelanotide for the treatment of acquired hypothalamic obesity: a phase 2, open-label, multicentre trial
Christian L. Roth, Cecilia Scimia, Ashley H. Shoemaker, Michael B. Gottschalk, Jennifer Miller, Guojun Yuan, Sonali Malhotra, M. Jennifer Abuzzahab
Topics & Concepts
MedicineOpen labelMelanocortin 4 receptorObesityAgonistMelanocortinInternal medicineAffect (linguistics)EndocrinologyRandomized controlled trialReceptorBioinformaticsCommunicationBiologySociologyRegulation of Appetite and ObesityDietary Effects on HealthPharmacology and Obesity Treatment